相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FOXC1: an emerging marker and therapeutic target for cancer
B. Han et al.
ONCOGENE (2017)
Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation
Jamie M. Sperger et al.
CLINICAL CANCER RESEARCH (2016)
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer
Christian P. Meyer et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
The incorporation of microfluidics into circulating tumor cell isolation for clinical applications
Molly Kozminsky et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer
Niven Mehra et al.
CLINICAL CANCER RESEARCH (2015)
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
David T. Miyamoto et al.
SCIENCE (2015)
Emerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis
Hyeun Joong Yoon et al.
ACS NANO (2014)
Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
Anne Schroeder et al.
CANCER RESEARCH (2014)
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto et al.
CELL (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
Klaus Pantel et al.
CANCER RESEARCH (2013)
Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets
Hyeun Joong Yoon et al.
NATURE NANOTECHNOLOGY (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The PSA-/Io Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
Jichao Qin et al.
CELL STEM CELL (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device
Brian J. Kirby et al.
PLOS ONE (2012)
Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer
David T. Miyamoto et al.
CANCER DISCOVERY (2012)
Circulating tumor cells: a window into cancer biology and metastasis
Shyamala Maheswaran et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody
Jason P. Gleghorn et al.
LAB ON A CHIP (2010)
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L. Stott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Margaret A. Leversha et al.
CLINICAL CANCER RESEARCH (2009)
δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles
Yan Zeng et al.
MOLECULAR CANCER (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study
Dominik R. Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
